Biodegradable magnesium alloy stents as a treatment for vein graft restenosis

15Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

Purpose: To explore the effects of biodegradable magnesium alloy stents (BMAS) on remodeling of vein graft (VG) anastomotic restenosis. Materials and Methods: To establish a VG restenosis model, seventy two New Zealand rabbits were randomly divided into three groups according to whether a stent was implanted in the graft vein or not. BMASs and 316L stainless steel stents were implanted in BMAS and 316L groups, respectively, while no stent was implanted in the no-treatment control group (NC group). Loss of lumen diameter in the graft vein was measured in all three groups. Upon harvesting VG segments to evaluate intimal proliferation and re-endothelization, the degradation and biological safety of the stents were observed to explore the effects of BMAS on VG remodeling. Results: Model establishment and stent implantation were successful. The BMAS reduced lumen loss, compared with the control group (0.05±0.34 mm vs. 0.90±0.39 mm, p=0.001), in the early stage. The neointimal area was smaller in the BMAS group than the 316L group after 4 months (4.96±0.66 mm2 vs. 6.80±0.69 mm2, p=0.017). Re-endothelialization in the BMAS group was better than that in the 316L group (p=0.001). Within 4 months, the BMAS had degraded, and the magnesium was converted to phosphorus and calcium. The support force of the BMAS began to reduce at 2-3 months after implantation, without significant toxic effects. Conclusion: BMAS promotes positive remodeling of VG anastomosis and has advantages over the conventional 316L stents in the treatment of venous diseases.

References Powered by Scopus

Clinical end points in coronary stent trials: A case for standardized definitions

5135Citations
N/AReaders
Get full text

2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention

2069Citations
N/AReaders
Get full text

Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial

1445Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Translational status of biomedical Mg devices in China

42Citations
N/AReaders
Get full text

Characterization of a sandwich plga-gallic acid-plga coating on mg alloy zk60 for bioresorbable coronary artery stents

27Citations
N/AReaders
Get full text

An Overview of In Vitro Drug Release Methods for Drug-Eluting Stents

18Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Li, Y., Wang, L., Chen, S., Yu, D., Sun, W., & Xin, S. (2019). Biodegradable magnesium alloy stents as a treatment for vein graft restenosis. Yonsei Medical Journal, 60(5), 429–439. https://doi.org/10.3349/ymj.2019.60.5.429

Readers over time

‘19‘20‘21‘22‘23‘24036912

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 19

90%

Researcher 2

10%

Readers' Discipline

Tooltip

Medicine and Dentistry 9

43%

Materials Science 6

29%

Engineering 4

19%

Pharmacology, Toxicology and Pharmaceut... 2

10%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 46

Save time finding and organizing research with Mendeley

Sign up for free
0